WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY – Get Free Report) gapped up before the market opened on Thursday. The stock had previously closed at $13.62, but opened at $14.3355. WuXi Biologics (Cayman) shares last traded at $14.30, with a volume of 1,079 shares.
Analyst Upgrades and Downgrades
Separately, Zacks Research upgraded shares of WuXi Biologics (Cayman) to a “hold” rating in a research report on Friday, August 28th. One research analyst has rated the stock with a Hold rating, According to data from MarketBeat, WuXi Biologics (Cayman) has a consensus rating of “Hold”.
View Our Latest Research Report on WuXi Biologics (Cayman)
WuXi Biologics (Cayman) Stock Performance
WuXi Biologics (Cayman) Company Profile
WuXi Biologics (Cayman) Inc is a global contract research, development and manufacturing organization (CRDMO) focused on biologic medicines. The company works with pharmaceutical and biotechnology customers to support the development and production of biologic therapies, including monoclonal antibodies, recombinant proteins, vaccines and other complex biological products.
Its services span early-stage discovery and cell-line development through process development, clinical manufacturing, regulatory support and commercial-scale production.
Read More
- Five stocks we like better than WuXi Biologics (Cayman)
- Apple’s $5.7 Billion Patent Verdict Raises a Bigger Royalty Question
- First Watch’s Growth Story Meets a Reality Check
- Down 50% and Climbing Again: 3 AI Stocks Rebuilding After Brutal Pullbacks
- Micron’s Earnings Reveal Why the AI Memory Boom May Last Longer
Receive News & Ratings for WuXi Biologics (Cayman) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WuXi Biologics (Cayman) and related companies with MarketBeat.com's FREE daily email newsletter.
